UTRECHT, the Netherlands -- Single Cell Discoveries, a Contract Research Organization (CRO) dedicated to single-cell sequencing, is proud to announce the first delivery of the new Illumina NovaSeq X Plus sequencing system in the Benelux. This milestone achievement solidifies Single Cell Discoveries' commitment to driving innovation and delivering high-impact insights to biopharmaceutical companies, health systems, and academic [...]

BetaLife wins top prize with its potential to provide regenerative medicines to patients with severe diabetes in Southeast Asia. Cytiva’s BioChallenge aims to support the innovation of biotech startups. Cytiva recognizes the talent, resource and scalability constraints faced by small to medium-sized biotechs in Southeast Asia. As such, it brought its global competition, BioChallenge, for [...]

TAIPEI, Taiwan and VACAVILLE, Calif. — Polaris Group (TWSE: 6550), a multinational biopharmaceutical company focused on research and development of novel biological drugs for cancer and other metabolic diseases, today announced that Polaris Group’s strategic partner, Nanotein Technologies, has just launched GROW-NK, a novel Natural Killer (NK) cell activation and expansion reagent. This reagent is [...]

World-class laboratory and office space underpins the scaling of Quantum-Si’s operational and development capabilities in support of its goal to revolutionize protein sequencing. Company continues rich 10 year history in Connecticut with new facility through 2029 BRANFORD, Conn. -- Quantum-Si- Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the official debut of [...]

Together, an extensive panel of consented patient samples and iPSC technology will advance AD drug development and patient stratification. CAMBRIDGE / EDINBURGH and ALDERLEY PARK, UK: Axol Bioscience Ltd. (Axol), a leading pluripotent stem cell technology provider for drug discovery has signed an exclusive agreement with StrataStem to access and commercialize its extensive collection of Alzheimer’s [...]

CARLSBAD, Calif. -- ChromaCode, a genomics multiplexing platform company developing accessible and affordable solutions for laboratories, patients and physicians, today announced a strategic investment from corporate venture capital fund Shimadzu Future Innovation Fund L.P., with general partner Global Brain Corporation. This funding will support ChromaCode's continued development of its HDPCR technology to deliver high quality, faster, [...]

Signing of an agreement by Dr. Kimberly Cline, President of Long Island University and Mr. Antoine Turzi, President of RegenLab USA LLC, for the creation of an industrial innovation accelerator dedicated to cell therapies and tissue engineering integrated into the "Dassault Systèmes Center of Excellence" Establishment of a teaching program with Long Island University, with [...]

Boxborough, MA – RedShiftBioAnalytics (RedShiftBioⓇ) today announced it was launching the HaLCon Analyzer, an advanced, fit-for-purpose, liquid chromatography platform designed to provide protein titer results equivalent to traditional protein A, HPLC with a faster, easier, and more cost-effective platform method. The HaLCon Analyzer integrates seamlessly into any bioprocessing suite without disrupting existing workflows or equipment and [...]

Vizgen Intends to Aggressively Defend Pioneering MERSCOPE Technology in Europe Just as it has in the U.S. Previous 10x Judgments Versus Competitors Have No Application to Vizgen Cases CAMBRIDGE, Mass. ---Vizgen, Inc. ("Vizgen" or the "Company"), a life science leader dedicated to improving human health by visualizing single-cell spatial genomics information, today issued the below [...]

On May 19, Shimadzu Corporation has invested in ChromaCode Inc. (ChromaCode), a startup with technology to expand genetic testing, through its corporate venture capital (CVC) fund, Shimadzu Future Innovation Fund L.P. (Shimadzu FIF). This is Shimadzu FIF's first investment. ChromaCode is a startup that expands the number of target genes available in existing PCR with [...]